He and colleagues characterized a polyunsaturated lipid (142) from the Chinese marine sponge Xestospongia testudinaria, which was shown to inhibit protein tyrosine phosphatase 1B, considered as a significant target for the “treatment of type II diabetes and obesity” [163]. This evidence concerns the gene PTPN1 and obesity disorder.